MG
Insider
Michelle Renee Griffin
DirectorMichelle Renee Griffin (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $1.1M of ADPT (52,084 sh × $20.18, as filed), executed Jun 25.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Jun 25
Filed Jun 29
Median ADV $72.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ADPTRecent filings
ADPTSALE
Adaptive Biotechnologies Corporation
View filing →
$1.1M52,084 sh × $20.18
Exec Jun 25
Filed Jun 29 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $214K
15,394 sh × $13.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $735K
48,044 sh × $15.30
Exec Mar 3
Filed Mar 5 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $261K
36,291 sh × $7.19
Exec Mar 13 2025
Filed Mar 17 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $124K
15,664 sh × $7.94
Exec Mar 6 2025
Filed Mar 6 2025 · 5:30 PM ET